For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Buspirone | This drug will be taken for two week period Buspirone: The initial dose of Buspirone is 15 mg daily (7.5 mg bid.). To achieve an optimal therapeutic response, at intervals of 2 to 3 days the dosage may be increased 5 mg per day until a maximum dose 30mg/day is reached. | 0 | None | 0 | 10 | 3 | 10 | View |
| Trazodone | This drug will be taken for two week period Trazodone: 100 mg dose before bed-time | 0 | None | 0 | 9 | 0 | 9 | View |
| Placebo | A placebo pill will be taken at bed time for two week period Placebo: One placebo pill before bed-time | 0 | None | 1 | 9 | 0 | 9 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Suicidal Thoughts | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |